<DOC>
	<DOCNO>NCT01111435</DOCNO>
	<brief_summary>This study expect contribute body knowledge benefit individual MS take glatiramer acetate ( Copaxone® ) . If patient le spasticity take glatiramer acetate ( Copaxone® ) , may likely improve quality life . The hypothesis study : 1 . Study participant transition interferon therapy glatiramer acetate ( Copaxone® ) six month period decrease spasticity . 2 . Study participant transition interferon therapy glatiramer acetate ( Copaxone® ) six month period change perception impact spasticity life .</brief_summary>
	<brief_title>A Prospective Study Spasticity Individuals With Multiple Sclerosis</brief_title>
	<detailed_description>The purpose study determine change spasticity perception impact spasticity individual multiple sclerosis transition interferon glatiramer acetate ( Copaxone® ) .• - Potential participant meet criterion identify Shared Solutions inform study . Interested individual contact investigator either email telephone . Enrollment continue 110 participant start glatiramer acetate ( Copaxone® ) . - Potential participant inform detail study , eligibility confirm , participant 's question answer . - The two study instrument sociodemographic questionnaire email mailed via UPS along information letter . May return either via email , fax UPS mail . - At month 6 participant , study instrument sociodemographic questionnaire send second time return investigator .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<criteria>Stopped interferon ( beta1a beta1b ) within past 30 day About start start glatiramer acetate ( Copaxone® ) within past 21 day . At least 18 year age Has spasticity begin study Able ambulate unilateral support without support Understands , speak read English Severe Gait Disability Total Gait Disability</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>